Drug Trial Radar · NCT02643420
SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)
Last checked: Nov 20, 2026Latest source record: Mar 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
406
Actual
Start
Jan 19, 2016
Primary completion
Jan 24, 2018
Study completion Oct 31, 2018
Sponsor
- Lead sponsor
- Spectrum Pharmaceuticals, IncIndustry
- Sponsor type
- Industry
- First posted
- Dec 31, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to compare the efficacy of a single dose of SPI-2012 versus pegfilgrastim in participants with early-stage breast cancer receiving docetaxel and cyclophosphamide (TC), as measured by the duration of severe neutropenia (DSN) in Cycle 1.
Conditions
- Neutropenia
- Breast Cancer
Interventions
SPI-2012Drug
Single-use syringes for subcutaneous injection, administered on Day 2 of each cycle
PegfilgrastimDrug
Single-dose subcutaneous injection administered on Day 2 of each cycle
DocetaxelDrug
Standard therapy
CyclophosphamideDrug
Standard therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Duration of Severe Neutropenia (DSN) in Cycle 1Time frame: Day 1 and Days 4-15 in Cycle 1 (each cycle was 21 days)
Locations
81 sites in 3 countries. Site status is shown where the registry gives one.
Arizona Center for Cancer Care
Glendale, Arizona
Arizona Clinical Research Center/ ACRC
Tucson, Arizona
Yuma Regional Medical Center
Yuma, Arizona
Genesis Cancer Center
Hot Springs, Arkansas
NEA Baptist Clinic | Fowler Family Center for Cancer Care
Jonesboro, Arkansas
Pacific Cancer Medical Center, Inc.
Anaheim, California
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center
Bakersfield, California
Alta Bates Summit Medical Center
Berkeley, California
Precision Research Institute, LLC
Chula Vista, California
Compassionate Cancer Care Medical Group, Inc.
Corona, California
Compassionate Care Research Group, Inc.
Fountain Valley, California
Long Beach Memorial Medical Center
Long Beach, California
Pacific Shores Medical Group
Long Beach, California
Ventura County Hematology-Oncology Specialists
Oxnard, California
Valley Medical Oncology Consultants
Pleasanton, California
Emad Ibrahim, MD, Inc.
Redlands, California
Compassionate Cancer Care Medical Group, Inc
Riverside, California
St Joseph Heritage Healthcare Institution
Santa Rosa, California
Wellness Oncology Hematology
West Hills, California
Oncology Institute of Hope and Innovation
Whittier, California
Omega Research Consultants LLC
DeBary, Florida
Pasco Pinellas Cancer Center
Holiday, Florida
AMPM Research Clinic
Miami, Florida
Lakes Research, LLC
Miami Lakes, Florida
Mid Florida Hematology and Oncology Centers
Orange City, Florida
Florida Cancer Research Institute
Plantation, Florida
Bond Clinic, P.A.
Winter Haven, Florida
John B Amos Cancer Center
Columbus, Georgia
Dwight D. Eisenhower Army Medical Center
Fort Gordon, Georgia
Memorial Health University Medical Center
Savannah, Georgia
Saint Alphonsus Regional Medical Center
Boise, Idaho
Clintell, Inc/Swedish Covenant Hospital
Chicago, Illinois
Joliet Oncology Hematology Associates
Joliet, Illinois
Oncology Specialists, SC
Park Ridge, Illinois
Swedish American Cancer Center
Rockford, Illinois
Carle Cancer Center
Urbana, Illinois
Franciscan St. Francis Health
Indianapolis, Indiana
Floyd Memorial Cancer Center of Indiana
New Albany, Indiana
Northern Indiana Cancer Research Consortium
Westville, Indiana
Ashland-Bellefonte Cancer Center
Ashland, Kentucky
Showing 40 of 81 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.